EXACT Sciences (NASDAQ:EXAS) and Bioanalytical Systems (NASDAQ:BASI) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations.

Profitability

This table compares EXACT Sciences and Bioanalytical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
EXACT Sciences -38.54% -23.29% -11.77%
Bioanalytical Systems -1.03% 3.28% 1.19%

Earnings & Valuation

This table compares EXACT Sciences and Bioanalytical Systems’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
EXACT Sciences $454.46 million 26.23 -$114.39 million ($1.36) -69.70
Bioanalytical Systems $26.35 million 0.76 -$190,000.00 N/A N/A

Bioanalytical Systems has lower revenue, but higher earnings than EXACT Sciences.

Analyst Ratings

This is a summary of recent ratings and recommmendations for EXACT Sciences and Bioanalytical Systems, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EXACT Sciences 0 1 11 0 2.92
Bioanalytical Systems 0 0 0 0 N/A

EXACT Sciences presently has a consensus price target of $99.70, indicating a potential upside of 5.18%. Given EXACT Sciences’ higher probable upside, equities analysts clearly believe EXACT Sciences is more favorable than Bioanalytical Systems.

Volatility & Risk

EXACT Sciences has a beta of 1.83, meaning that its stock price is 83% more volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500.

Institutional and Insider Ownership

89.4% of EXACT Sciences shares are held by institutional investors. Comparatively, 8.8% of Bioanalytical Systems shares are held by institutional investors. 3.2% of EXACT Sciences shares are held by insiders. Comparatively, 7.8% of Bioanalytical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

About EXACT Sciences

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

About Bioanalytical Systems

Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment also provides in vivo sampling services for the continuous monitoring of chemical changes in life; non-clinical and pathology services; analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; and climate-controlled archiving services for its customers' data and samples. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Receive News & Ratings for EXACT Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EXACT Sciences and related companies with MarketBeat.com's FREE daily email newsletter.